SA
PFE icon

Sovran Advisors’s Pfizer PFE Stock Holding History

Sovran Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Sell
23,935
-411
-2% -$10.8K 0.05% 342
2026
Q1 		$650K Buy
24,346
+4,988
+26% +$133K 0.05% 309
2025
Q4 		$501K Buy
19,358
+9,084
+88% +$229K 0.04% 342
2025
Q3 		$250K Buy
10,274
+2,458
+31% +$60.7K 0.02% 465
2025
Q2 		$200K Sell
7,816
-25,471
-77% -$594K 0.02% 482
2025
Q1 		$737K Sell
33,287
-1,617
-5% -$42.3K 0.1% 218
2024
Q4 		$922K Buy
+34,904
New +$947K 0.13% 163

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sovran Advisors's PFE Position: Q2 2026 in Review

Sovran Advisors reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $10.8K and leaving 23,935 shares worth $604K. The position accounts for 0.05% of the portfolio, ranked #342.

Sovran Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $922K in Q4 2024. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sovran Advisors held 23,935 shares of Pfizer worth $604K as of Q2 2026.
  • Sovran Advisors sold 411 Pfizer shares in Q2 2026, an estimated $10.8K.
  • Pfizer made up 0.05% of Sovran Advisors's portfolio in Q2 2026, its #342 holding.
  • Sovran Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Sovran Advisors's Pfizer position peaked at $922K in Q4 2024.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.